Format

Send to

Choose Destination
See comment in PubMed Commons below
J Biomed Biotechnol. 2011;2011:986491. doi: 10.1155/2011/986491. Epub 2011 May 14.

The role of natural killer cells in sepsis.

Author information

1
Centre d'Immunologie de Marseille-Luminy, Université de la Méditerranée UM 631, Campus de Luminy, 13288 Marseille, France. laurent.chiche@ap-hm.fr

Abstract

Severe sepsis and septic shock are still deadly conditions urging to develop novel therapies. A better understanding of the complex modifications of the immune system of septic patients is needed for the development of innovative immunointerventions. Natural killer (NK) cells are characterized as CD3(-)NKp46(+)CD56(+) cells that can be cytotoxic and/or produce high amounts of cytokines such as IFN-γ. NK cells are also engaged in crosstalks with other immune cells, such as dendritic cells, macrophages, and neutrophils. During the early stage of septic shock, NK cells may play a key role in the promotion of the systemic inflammation, as suggested in mice models. Alternatively, at a later stage, NK cells-acquired dysfunction could favor nosocomial infections and mortality. Standardized biological tools defining patients' NK cell status during the different stages of sepsis are mandatory to guide potential immuno-interventions. Herein, we review the potential role of NK cells during severe sepsis and septic shock.

PMID:
21629707
PMCID:
PMC3100670
DOI:
10.1155/2011/986491
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Hindawi Publishing Corporation Icon for PubMed Central
    Loading ...
    Support Center